- Home
- ELDN vs OPRT Comparison
ELDN vs OPRT Comparison
Compare ELDN & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- OPRT
- Stock Information
- Founded
- ELDN 2004
- OPRT 2005
- Country
- ELDN United States
- OPRT United States
- Employees
- ELDN N/A
- OPRT N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- OPRT Finance: Consumer Services
- Sector
- ELDN Health Care
- OPRT Finance
- Exchange
- ELDN Nasdaq
- OPRT Nasdaq
- Market Cap
- ELDN 178.4M
- OPRT 221.5M
- IPO Year
- ELDN N/A
- OPRT 2019
- Fundamental
- Price
- ELDN $3.17
- OPRT $6.15
- Analyst Decision
- ELDN Strong Buy
- OPRT Hold
- Analyst Count
- ELDN 1
- OPRT 2
- Target Price
- ELDN $16.00
- OPRT $5.00
- AVG Volume (30 Days)
- ELDN 150.4K
- OPRT 313.8K
- Earning Date
- ELDN 05-20-2025
- OPRT 05-08-2025
- Dividend Yield
- ELDN N/A
- OPRT N/A
- EPS Growth
- ELDN N/A
- OPRT N/A
- EPS
- ELDN N/A
- OPRT N/A
- Revenue
- ELDN N/A
- OPRT $763,617,000.00
- Revenue This Year
- ELDN N/A
- OPRT $28.71
- Revenue Next Year
- ELDN N/A
- OPRT $9.89
- P/E Ratio
- ELDN N/A
- OPRT N/A
- Revenue Growth
- ELDN N/A
- OPRT N/A
- 52 Week Low
- ELDN $2.00
- OPRT $2.37
- 52 Week High
- ELDN $5.54
- OPRT $9.25
- Technical
- Relative Strength Index (RSI)
- ELDN 48.82
- OPRT 66.08
- Support Level
- ELDN $2.85
- OPRT $4.77
- Resistance Level
- ELDN $3.51
- OPRT $5.68
- Average True Range (ATR)
- ELDN 0.25
- OPRT 0.30
- MACD
- ELDN 0.01
- OPRT 0.16
- Stochastic Oscillator
- ELDN 45.07
- OPRT 96.26
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.